|
||||
|
|
||||
 |
||||||
 |
Human Gastrafate Rx is an Exciting new
product. It represents the first of the "2nd Generation Sucralfate", a product that can treat Symptomatic Acid Reflux, GERD, Esophageal Erosions, Gastric and Duodenal Ulcer and even H. Pylori Gastritis as a single agent therapeutic. COMMERCIAL USE |
Broad Range of Therapeutic Effects Preliminary findings of our clinical scientists show Human Gastrafate Rx to have a broad range of therapeutic effects · Near Immediate relief of GERD Pain · Near Immediate Relief of Nausea ·Three day 95% Reduction of H. Pylori without antibiotics · Healing GI erosions, Ulcerations within 10 days of use HIGH DEGREE OF BIOADHERENCE--HIGH POTENCY This patented specialized formulation of sucralfate has a surface adherence ("stickiness") that is 7 times that of regular sucralfate for normal gastrointestinal lining and 23 times that of regular sucralfate for acid irritated, ulcerated gastrointestinal lining. Surface Active Molecular Mechanisms It is presently known that sucralfate activates tissue healing factors and directly set in motion molecular processes to heal erosions, ulcers and irritations. It also intertwines with existing mucous blanket of the GI tract to make it more resistant to acid injury. |
FDA Status in USA Human Gastrafate Rx is curently under study for approval in the USA under is INDA. If you have interest in joining our group of investigators and the clinical trials that are ongoing internationally, please contact us by email. Glencopelph@aol.com |
 |
||
 |
||||||